Abstract

Introduction: Reverse transcription-polymerase chain reaction (RT-PCR) and chest X-ray (CXR) are commonly used techniques for diagnosing and assessing prognosis in patients with coronavirus disease-2019 (COVID-19). This study aims to highlight the long-term radiological findings observed on CXR after recovery, in patients with COVID-19. This will help identify patients suffering from long-term consequences of COVID-19 and help them provide adequate care.Methods: This study was conducted in the COVID-19 unit of a tertiary care hospital, Pakistan from August 2020 to February 2021. CXR of patients who were being discharged after negative PCR was done. Participants with positive X-ray findings, which included consolidation, reticular thickening, ground-glass opacities (GGO), pulmonary nodules, and pleural effusions, were enrolled in the study after getting informed consent. All findings were recorded in a self-structured questionnaire. Participants were scheduled to come for follow-up on day 30 after their initial CXR, where their CXR was repeated.Result: Our results showed that n=429 (60.2%) participants had positive CXR at the time of discharge. After 30 days, n=371 participants returned for a follow-up X-ray. Out of the 371 participants, after 30 days, 123 participants still had positive CXR. Fatigue (41.4%) was the common symptom after 30 days. The most common finding was consolidation (82.1%), followed by reticular thickening (23.5%) on day 30.Conclusion: In this study, although most of the patients completely recovered serologically from COVID-19, they still had radiological findings in their chest X-rays. Radiological findings are especially important in predicting the clinical course of the disease and may be used to monitor long-term complications.

Highlights

  • Reverse transcription-polymerase chain reaction (RT-PCR) and chest X-ray (CXR) are commonly used techniques for diagnosing and assessing prognosis in patients with coronavirus disease2019 (COVID-19)

  • This study was conducted in the COVID-19 unit of a tertiary care hospital, Pakistan from August 2020 to February 2021

  • The diagnosis is confirmed by reverse transcription-polymerase chain reaction (RT-PCR) of samples obtained from oropharyngeal or nasopharyngeal mucosa and is supported by parenchymal changes seen on chest imaging [6,7]

Read more

Summary

Introduction

Reverse transcription-polymerase chain reaction (RT-PCR) and chest X-ray (CXR) are commonly used techniques for diagnosing and assessing prognosis in patients with coronavirus disease2019 (COVID-19). This study aims to highlight the long-term radiological findings observed on CXR after recovery, in patients with COVID-19. This will help identify patients suffering from long-term consequences of COVID-19 and help them provide adequate care. In the most severe cases, COVID-19 can lead to severe acute respiratory syndrome, respiratory failure, multi-organ failure with the resultant high mortality [4,5]. The diagnosis is confirmed by reverse transcription-polymerase chain reaction (RT-PCR) of samples obtained from oropharyngeal or nasopharyngeal mucosa and is supported by parenchymal changes seen on chest imaging [6,7]. The more common radiological changes noted on the chest imaging include ground-glass opacities (GGO) and consolidations while cavitation, pleural effusions, pleural thickening, bronchiectasis, and lymphadenopathy occur less frequently [8,9,10]

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call